Belite Bio: Canaccord Genuity raises target price to $314 from $303
BLTE•Canaccord Genuity raised its target price for Belite Bio to $314 from $303.
Related News
Jaguar Health to host webcast on Q3 financial results
JAGX•
Vicor showcases 48V power solutions at EdgeTech+
VICR•
Vertiv introduces high-density remote power panel for next-generation AI data centers
VRT•
Health in Tech Q3 2026 adjusted EBITDA swings to $3.9 million loss
HIT•
Mobility Global Inc.: Wells Fargo raises target price to $29 from $23
MBGL•